Sanuwave Health, Inc. SNWV 深 沪
等待开盘 11-04 09:30:00 美东时间
27.42
-1.520
-5.25%
华盛通- 最 高29.73
- 今 开29.46
- 成交量 23.80万股
- 最 低 27.33
- 昨 收 28.94
- 总市值 2.35亿
- 52周最高 46.585
- 市盈率 静 --
- 换手率 2.78%
- 52周最低 24.80
- 委 比 56.56%
- 总股本 856.80万
- 历史最高 46.585
- 量 比 1.78
- 振 幅 8.29%
- 历史最低 24.80
- 每 手 1
- 风险率 4.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sanuwave Health Said Centers For Medicare & Medicaid Services' 2026 Rates For Physician Offices, Home Visits, Long-term Care, And Hospitals Are In Line With The Proposed Rule And Remain Materially Unchanged From 2025
Reimbursement for the 97610 code for UltraMIST products remains materially unchanged for 2026 with payment for treatment provided in the physician office, home visit, long-term care, and hospital settings remaining
11-03 18:05
Sanuwave Health Terminates President Andrew Walko
Sanuwave Health ( ($SNWV) ) just unveiled an update. On September 25, 2025, San...
10-31 05:28
SANUWAVE Health shares are trading lower after the company issued preliminary Q3 revenue results below estimates. Also, the company cut its FY25 revenue guidance.
SANUWAVE Health shares are trading lower after the company issued preliminary Q...
10-07 04:25
Sanuwave Health expects Q3 revenue between $11.4M and $11.6M
Sanuwave Health (NASDAQ:SNWV) announced on Monday that its revenues for the third quarter of 2025 are expected to be in the range of $11.4 to $11.6 million versus consensus of $12.37 million, an incre...
10-07 04:10
Sanuwave refinances debt with new credit facility
Sanuwave Health (NASDAQ:SNWV) has announced the refinancing of its $27.5M debt facility with a $23.0M new secured credit facility from J.P. Morgan, 1.0M withdrawn from a two-year $5.0M revolving credi...
09-26 22:46
Sanuwave Announces Strategic Debt Refinancing with New Credit Facility
<p><p align="center"><em>Credit facility from J.P. Morgan consists of a four-year term loan of $23 million and a two-year $5 million revolving credit facility backed by accounts receivable</em></p> <p align="center"><em>Both the term loan and revolver have an interest rate of SOFR +350bp</em></p> <p align="center"><em>The Company drew approximately $1 million from the revolver at commencement, resulting in total outstanding debt under the new fac...
09-26 11:00
美股大行评级 | 潜在涨幅403.28%！瑞杰金融首予Kalaris Therapeutics"强烈买入"评级，目标价23美元
今日重点评级关注：花旗：维持Ionis Pharmaceuticals"买入"评级，目标价从69美元升至84美元；Melius Research：上调康明斯评级至"买入"，目标价500美元
09-04 09:49
Northland Capital Markets Initiates Coverage On SANUWAVE Health with Outperform Rating, Announces Price Target of $55
Northland Capital Markets analyst Carl Byrnes initiates coverage on SANUWAVE Health (NASDAQ:SNWV) with a Outperform rating and announces Price Target of $55.
09-04 02:13
美股大行评级 | 英伟达、Snowflake、万国数据、沃尔玛、Target等均获大行上调目标价
今日重点评级关注：杰富瑞：维持aTyr Pharma"买入"评级，目标价从9美元升至17美元；花旗：维持Ionis制药"买入"评级，目标价从65美元升至69美元
08-25 08:34
Sanuwave Health rises after $5M payment related to patent sale
Sanuwave (NASDAQ:SNWV) shares rose after it announced that it has received a $5M cash payment from its third-party licensee in connection with the exercise of a previously granted acquisition option. ...
08-23 03:11
